We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Affymax Announces Promotion of Michael Holfinger

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Affymax Announces Promotion of Michael Holfinger"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Affymax, Inc. has announced the promotion of Michael Holfinger, Ph.D., to vice president, manufacturing and CMC development.

Dr. Holfinger, who has more than two decades of experience in global manufacturing services for pharmaceutical and biotechnology companies, joined Affymax in 2006 as director, process development and manufacturing.

“During his tenure at Affymax, Mike has shown impressive leadership skills and made significant contributions to our process and manufacturing development program for OMONTYS,” said John Orwin, chief executive officer of Affymax.

Orwin continued, “Looking ahead, his proven track record of overseeing complex commercial production at a global level and his intimate familiarity with the manufacturing process we have developed with our partner, Takeda, will be essential as we increase commercial production.”

Prior to joining Affymax, Dr. Holfinger held multiple positions at Pfizer, including most recently as senior manager in the API support team where he was responsible for change management, project management and technical support activities necessary to ensure an economical uninterrupted commercial supply of pharmaceutical ingredients for various products.

Prior to Pfizer, Dr. Holfinger held multiple positions within the chemical process research and development group at Pharmacia Corporation, where he was responsible for implementation of commercial processes for the manufacturing of chemical intermediates and active pharmaceutical ingredients.

From 1997-2004, he was a course instructor at the Pharmaceutical Education & Research Institute.

He earned his Ph.D. in chemical engineering from the University of Wisconsin-Madison and received a dual B.S. degree in applied science, paper science, and engineering and chemistry at Miami University.